Relaxin-3

• Description :

  Relaxin-3 (H3 relaxin, Insulin-like peptide-7, INSL7) is a secreted protein structurally related to insulin, which is expressed primarily in the brain and central nervous system. Relaxin-3 has been identified as the ligand for the GPCR135 receptor, previously known as “somatostatin-like” or “angiotensin-like” peptide receptor, and also binds specifically to the LGR7 receptor, previously identified as an “orphan” G protein coupled receptor. Signaling by Relaxin-3 through its target receptors is, most likely, part of a CNS processing system, activated in response to signaling by neuropeptides and other factors. Intracerebroventricular injections of Relaxin-3 have been shown to cause a significant increase of food intake and body weight in Wistar rats. Recombinant Relaxin-3 is a 5.5 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 27 amino acid B-chain.

• Synonyms :

  RLN3; H3; RXN3; ZINS4; insl7

• NCBI Gene ID :

  117579

• UniProt :

  Q8WXF3

• Accession Number :

  NP_543140.1

• Accession Number mRNA :

  NM_080864

• Chromosomal Location :

  19p13.2

• Reactivity :

  Human

• Cross Reactivity :

  Human

• Sequence :

  A-chain: DVLAGLSSS CCKWGCSKSE ISSLC; B-chain: RAAPYGVRL CGREFIRAVI FTCGGSRW

• Endotoxin :

  < 0.1 ng/µg of protein (< 1EU/µg)

• Purity :

  > 98% by SDS-PAGE & HPLC analyses

• Bioactivity :

  Data not available.

• Length :

  51

• Form :

  Lyophilized

• Molecular Weight :

  5.5 kDa

• Host or Source :

  E. coli